Global Cetuximab Market to Reach $61.2M by 2034, Driven by Targeted Cancer Therapies & Precision Oncology
Global Cetuximab Market to Reach $61.2M by 2034, Driven by Targeted Cancer Therapies & Precision Oncology
According to new market intelligence from Intel Market Research, the global Cetuximab market was valued at USD 48.8 million in 2024 with projections showing steady growth to USD 61.2 million by 2034, representing a CAGR of 3.4% during the forecast period. This expansion reflects the increasing adoption of targeted cancer therapies and improvements in precision medicine approaches for EGFR-positive malignancies.
???? Download Sample Report:https://www.intelmarketresearch.com/download-free-sample/34916/cetuximab-market
Key Market Drivers
1. Rising Cancer Burden and EGFR-Targeted Treatment Adoption
The World Health Organization reports approximately 1.9 million new colorectal cancer cases annually, with EGFR amplification present in 50-80% of cases. Cetuximab's ability to extend progression-free survival by 42% in metastatic CRC regimens (per NCCN clinical guidelines)
